Revelation Biosciences Earnings beat, Revenue Inline In Q3
Investing.com - Revelation Biosciences reported on Thursday third quarter {{erl-1184125||earnings that beat analysts' forecasts and revenue that was inline with expectations. Revelation...
Neutral
or
Revelation Biosciences News & Analysis
-
-
Revelation Biosciences Stock Soars After Encouraging Preclinical Data From Kidney Disease Candidate
Revelation Biosciences Inc (NASDAQ: REVB) announced positive results in a preclinical model of acute kidney injury (AKI), a chronic kidney disease (CKD). Treatment with REVTx-300...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.82%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Oil & Gas, Technology and Basic Materials sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.05%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Oil & Gas, Technology and Basic Materials sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.19%
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Consumer Services, Technology and Financials sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.00%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Technology, Basic Materials and Financials sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average unchanged
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Telecoms, Utilities and Oil & Gas sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
